MRI在前列腺癌检测中的应用：您会从中受益吗？

最后更新： 2026年8月15日

• WordPress的
• LinkedIn
• 邮件

Today we are going to talk about MRI of the prostate. As I have often explained when discussing prostate cancer, this disease is frequently limited in aggressiveness. The story usually begins with a rising Prostate-Specific Antigen (PSA) blood test from a routine health check-up, which brings the patient to a urology clinic to weigh the pros and cons of a tissue biopsy and, ultimately, to reach a diagnosis. The important question is this: does every man with a suspicious PSA really need a biopsy? The answer is very often no — and here is the evidence behind that.

Autopsy studies of men who died of unrelated causes have long shown that a substantial proportion of older men are walking around with prostate cancer that never troubled them in life — and that a large share of those cancers are low-grade disease that would never have required treatment. In other words, finding a cancer is not the same as finding a cancer worth treating.

This matters because a needle biopsy of the prostate is not a trivial procedure. It can cause blood in the urine, blood in the stool, blood in the semen, and — uncommonly but importantly — a serious bloodstream infection. In the PROMIS study, close to 6% of participants reported a serious adverse event, including eight cases of sepsis.

When a biopsy is genuinely necessary, it should absolutely be done. The real challenge is knowing how to avoid the unnecessary ones. This is where MRI of the prostate has become an essential tool for urologists. Here are its main advantages and limitations.

Advantages of prostate MRI

• It is a non-invasive imaging test that provides a great deal of detail about the anatomy of the prostate gland.
• It is far more sensitive than a blind biopsy. In the PROMIS study, multiparametric MRI detected 93% of clinically significant cancers, compared with just 48% for standard transrectal ultrasound-guided biopsy.
• A negative scan is reassuring. PROMIS reported a negative predictive value of 89% for clinically significant cancer, which is what makes MRI usable as a triage test before biopsy.
• It lets many men skip the biopsy altogether. PROMIS estimated that using MRI to triage would allow about 27% of men to avoid a primary biopsy; in the PRECISION trial, 28% of men in the MRI arm had a scan that was not suspicious and were not biopsied at all.
• When a biopsy is needed, targeting finds more of the cancers that matter. In PRECISION, MRI-targeted biopsy diagnosed clinically significant cancer in 38% of men versus 26% with standard biopsy — using a median of only 4 cores instead of 12.
• It reduces overdiagnosis. PRECISION also found 13 percentage points fewer diagnoses of clinically insignificant cancer in the MRI-targeted group — fewer men labelled with a cancer that was never going to harm them.

Limitations of prostate MRI

• It is expensive compared with conventional ultrasound.
• It is not very specific. In PROMIS, specificity was only 41% and the positive predictive value 51% — meaning a suspicious-looking area is roughly a coin flip, and a scan that looks abnormal still has to be confirmed by biopsy.
• Some scanners require an endorectal coil to be placed in the rectum to improve image quality, which many men find uncomfortable.
• A negative scan is reassuring, not a guarantee. A small number of significant cancers are still missed, which is why men with a negative MRI need continued PSA follow-up rather than simple discharge.

Few diagnoses cause as much anxiety as suspected prostate cancer, and I hope this article helps you understand your options more clearly. If you have further questions, please discuss them with a urologist you trust.

在影像学和活检证实存在明显癌症的情况下，手术通常是最终的治疗方案。了解 达芬奇前列腺癌手术 以及现实中的康复包括哪些方面。.

If you have an elevated PSA and would like an MRI prostate evaluation before considering a biopsy, Dr. Soarawee Weerasopone offers specialist consultations at Bangkok Hospital Headquarters. 预约咨询.

MRI前列腺常见问题解答

核磁共振成像（MRI）前列腺检查用于什么？

前列腺核磁共振是一种非侵入性成像工具，用于评估前列腺特异性抗原（PSA）水平升高的男性前列腺。它有助于泌尿科医生识别可能预示侵袭性前列腺癌的可疑区域，并决定是否需要进行活检，从而减少不必要的侵入性手术。.

MRI前列腺在检测癌症方面的准确性如何？

In the PROMIS study, multiparametric MRI detected 93% of clinically significant prostate cancers, compared with 48% for standard transrectal ultrasound-guided biopsy, with a negative predictive value of 89%. Its weakness is specificity, which was 41%, so a suspicious scan still needs biopsy confirmation. In the PRECISION trial, MRI-targeted biopsy diagnosed clinically significant cancer in 38% of men versus 26% with standard biopsy.

MRI前列腺可以取代前列腺活检吗？

No, MRI prostate cannot fully replace biopsy. If MRI shows suspicious findings, a biopsy is still required to confirm the diagnosis. However, MRI can spare a large number of men the procedure entirely: PROMIS estimated that around 27% of men could avoid a primary biopsy, and in PRECISION 28% of men in the MRI arm had a non-suspicious scan and were not biopsied.

MRI前列腺的缺点是什么？

MRI prostate is more expensive than standard ultrasound, and it has limited specificity — 41% in the PROMIS study — so abnormal scans often turn out not to be significant cancer. In some cases an endorectal coil must be inserted into the rectum to improve image quality, which can be uncomfortable. It is also not a definitive diagnostic test, so a biopsy is still needed when findings are suspicious, and a small number of significant cancers can be missed.

谁应该考虑做前列腺核磁共振？

PSA水平升高、直肠指检异常或既往活检阴性但仍怀疑前列腺癌的男性是前列腺MRI的最佳候选者。您的泌尿科医生将评估您的具体情况，并推荐最合适的影像学检查策略。.

参考

1. Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815–822. PubMed
2. Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis (PRECISION). N Engl J Med. 2018;378(19):1767–1777. PubMed

**免责声明：** 本内容由曼谷医院总院的认证泌尿科医生 Soarawee Weerasopone 医生撰写和审阅。本内容仅用于教育目的，不构成医疗建议。在开始任何医疗治疗前，请务必咨询合格的医疗专业人士。.